Study details
Enrolling now
Ferric Citrate and Chronic Kidney Disease in Children
University of California, Los Angeles
NCT IDNCT04741646ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
160
Study length
about 5.4 years
Ages
6–18
Locations
18 sites in CA, FL, GA +8
What this study is about
Researchers are testing whether ferric citrate (FC) can help change levels of a substance called intact FGF23 in children with chronic kidney disease. The trial will last 1962 days and involve about 160 children aged 6-18 years old, randomly assigned to either receive FC or a placebo.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Ferric Citrate
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
ferric citrate
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Tolerability of Ferric Citrate
Body systems
Renal